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What is the key question? 
Is the variation in surgical resection rates for non-small cell lung cancer based on where the patient is 
first seen and the catchment population of surgical centres in England? 
What is the bottom line? 
The likelihood of having surgery is independently influenced by patient features and where the patient 
is first seen (either a surgical or non-surgical centre), and a strong association exist between the size 
of a surgical centre catchment population and which patients had surgery. 
Why read on? 
Findings suggest that there is a need to redesign lung cancer services to allow more patients not first 
seen in a surgical centre to have equal access to surgery. 
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ABSTRACT 
Objectives 
To determine the influence of where a patient is first seen (either surgical or non-surgical centre) and 
patient features on having surgery for non-small cell lung cancer (NSCLC). 
Design 
Cross sectional study from individual patients, 1
st
 January 2008 to 31
st
 March 2012 
Setting 
Linked National Lung Cancer Audit (NLCA) and Hospital Episode Statistics (HES) datasets 
Participants 
95,818 English patients with a diagnosis of NSCLC, of whom 12,759 (13%) underwent surgical 
resection. 
Main outcome measure 
Odds of having surgery based on the empirical catchment population of the 30 thoracic surgical 
centres in England and whether the patient is first seen in a surgical centre or a non-surgical centre. 
Results 
Patients were more likely to be operated on if they were first seen at a surgical centre (OR 1.37; 95% 
CI 1.29 – 1.45). This was most marked for surgical centres with the largest catchment populations. In 
these surgical centres with large catchment populations, the resection rate for local patients was 18%, 
and for patients first seen in a non-surgical centre within catchment was 12%. 
Conclusion 
Surgical centres that serve the largest catchment populations have high resection rates for patients first 
seen in their own centre but, in contrast, low resection rates for patients first seen at the surrounding 
centres they serve. Our findings demonstrate the importance of going further than relating resection 
4 
 
rates to hospital volume, or surgeon number, and show that there is a pressing need to design lung 
cancer services which enable all patients, including those first seen at non-surgical centres, to have 
equal access to lung cancer surgery. 
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INTRODUCTION 
Non-small cell lung cancer (NSCLC) accounts for almost 85% of all lung cancer cases diagnosed in 
England,[1, 2] and for these people surgical resection offers the best chance for cure and long term 
survival.[3, 4] Compared with other European countries and North America, England has poor overall 
survival and lower resection rates.[5, 6] Patients with stage I or II disease, who are a minority of those 
diagnosed, are believed to benefit from surgical resection.[4, 7] In a previous study we have shown 
that patients first seen at a surgical centre were more likely to have surgery than patients who were not 
first seen in a surgical centre.[3] In addition, patients have a better survival if their operation is in a 
high volume surgical centre.[1] 
The National Lung Cancer Audit (NLCA) commissioned by the Healthcare Quality Improvement 
Partnership (HQIP) was established in 2004 to measure the quality of services provided by National 
Health Service (NHS) hospitals to patients with lung cancer in order to improve outcomes.[3, 4] There 
are 157 NHS centres, of which 30 centres offer thoracic surgery and have a thoracic or cardiothoracic 
surgeon on site. Almost all patients with lung cancer are discussed by the multidisciplinary team 
(MDT) at each centre where they are first seen, with thoracic surgeons attending in person or via 
video conferencing from the 30 centres where thoracic surgical operations are performed (here after 
referred to as ‘surgical centres’). Thus a surgical centre’s catchment population is considerably larger 
than that of an individual NHS centre and it is possible that the size of this catchment population and 
the lung cancer burden that comes with it could influence access to surgery. To date there have been 
no studies quantifying the catchment population or assessing whether the size of the lung cancer 
catchment population is related to an individual patient’s likelihood of having surgery. 
We used data from the NLCA database linked with the Hospital Episode Statistics (HES) inpatient 
data from 2008 to 2012 to quantify the impact of individual patient features and size of surgical centre 
lung cancer catchment population on the likelihood of having surgery for NSCLC. 
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METHODS 
Database 
The validated NLCA database [8] is a longitudinal database started in 2004 by the Royal College of 
Physicians, which consists of anonymised records of individuals with a diagnosis of lung cancer 
collected via the 157 NHS centres in England. The NLCA database currently holds records for over 
225,000 patients, with approximately 40,000 added in 2011. The ascertainment of cases and data 
completeness has improved considerably from 2008 onwards.[9] The NLCA has been linked with the 
Hospital Episode Statistics (HES) inpatient data and Office for National Statistics (ONS) to enhance 
the available data and provide date of death. 
Study population 
We conducted a cross-sectional analysis and used data on all patients in the NLCA who were first 
diagnosed in England between 1
st
 January 2008 and 31
st
 March 2012 and had proven or presumed 
NSCLC. Patients who were diagnosed through their death certificate were excluded from further 
analyses as were patients with small-cell lung cancer, mesothelioma or carcinoid tumours. In line with 
the methods used by the NLCA to define lung cancer type, we identified cases of pathologically 
confirmed ‘non-small cell lung cancer’ based on the recorded Systematised Nomenclature of 
Medicine (SNOMED) codes, while cases without a pathologically confirmed diagnosis or ‘unknown 
lung cancer’ SNOMED code were also classified as NSCLC; this is in line with the standard NLCA 
definition of NSCLC.[9, 10] 
Covariates 
Age at diagnosis, sex, socioeconomic status and source of referral to the MDT were identified from 
the NLCA. Performance status (PS) was classified according to the World Health Organisation 
definition and stage of the disease was defined using the Union for International Cancer Control 
definition, both are recorded in the NLCA. We used the HES database to calculate a composite score 
of co-morbidity: the Charlson co-morbidity Index, and to obtain information on ethnicity. We used 
Office of Population Censuses and Survey Classification of Intervention (OPCS-4) codes in the HES 
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database to identify procedures consistent with potentially curative surgery for NSCLC as has been 
described previously.[4, 11] In addition, we included patients who had evidence of having surgery in 
NLCA database only (1% additional patients). 
Surgical centre lung cancer catchment population 
In England, people with lung cancer are operated on at one of the 30 thoracic surgical centres, which 
have thoracic or cardiothoracic surgeons on site, who perform all lung cancer resections. To calculate 
a catchment population representing the total number of patients with lung cancer that a surgical 
centre is responsible for, we used data on the distribution of surgically resected patients between 
surgical centres and the total number of lung cancer patients first seen at each of the 157 centres. For 
128 centres (80%), all of their resected patients were operated on at a single surgical centre and so all 
lung cancer patients (whether they had surgery or not) from these centres were allocated to the 
catchment population of that surgical centre. Where a centre had patients who were operated on at 
more than one surgical centre, their total number of lung cancer patients were allocated to each of 
these centres’ catchment population in the same ratio as the operated patients. Using this method, all 
the patients with NSCLC, including the non-operated patients, were allocated to the catchment 
population of one of the 30 surgical centres in England to derive a ‘lung cancer catchment 
population’. 
The annual lung cancer patient catchment population for each surgical centre was calculated and 
categorised as follows: <400 patients/year (7 centres), 400 to 700 patients/year (7 centres), 700 to 
1100 patients/year (9 centres) and >1100 patients/year (7 centres). This division of the surgical 
centres, was done in order to create quartiles with an almost equal number if surgical centres. We also 
collected data on the number of surgeons working in each surgical centre in 2010 through an online 
questionnaire sent to the members of Society for Cardiothoracic Surgeons. The information collected 
via this questionnaire only reflect the number of cardiothoracic surgeons on site, and it does not 
reflect the number of whole time equivalent (WTE) surgeons nor their level of involvement in lung 
cancer surgery. 
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Statistical analysis 
All data and statistical management were performed using Stata version 12 (StataCorp, USA). We 
used multivariate logistic regression analyses to estimate the odds of having surgery (odds ratios 
(ORs)) by patient and surgical centre features. We also performed a sensitivity analysis by restricting 
our dataset to patients with stage I and II NSCLC. 
We used logistic regression analyses to estimate odds of having surgery for patients first seen in a 
surgical centre verses patients first seen in a non-surgical centre. We looked for interaction between 
where the patient was first seen and the surgical centre lung cancer catchment population.  
Pearson correlation analysis was used to quantify the relationship between the surgical centre 
catchment population and number of surgeons on site. 
RESULTS 
Our dataset consisted of 120,050 patients who were diagnosed with lung cancer between 1
st
 January 
2008 and 31
st
 March 2012. We excluded 20,398 (17%) patients who were diagnosed as having small-
cell lung cancer, mesothelioma or carcinoid tumours; and 554 (0.4%) patients for whom we could not 
generate a start date. We excluded a further 2,555 (2%) patients who did not have information on 
centre of diagnosis (or centre of surgery if they had a surgical resection) and 725 (0.6%) patients who 
could not be redistributed to one of the 30 surgical centres due to miscoding. Therefore our analysis 
was based on 95,818 patients. The median age at diagnosis was 72 years (interquartile range 64 – 79), 
64% (n=54,074) of the patients were male, 42% (n=40,302) were categorised as PS 0 or 1 and 41% 
(n=39,505) had stage IV disease. Thirteen per cent (n=12,759) of our cohort had a record of surgery in 
either HES or NLCA.  
Table 1 presents an overview of the unadjusted and adjusted ORs of having surgery by patient 
features. A lower proportion of men had surgery compared with women (adjusted OR 0.94, 95% 
confidence interval (CI) 0.89 – 0.98). Increasing age, worsening PS and advanced stage disease were 
all associated with reduced odds of having surgery (p-values <0.001), while patients referred from the 
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emergency department had the lowest odds of having surgery compared with referral from a General 
Practioner (GP). There was evidence that patients from the least affluent areas were less likely to have 
surgery (χ2 p-value for trends <0.001). 
Surgical centre catchment population for lung cancer patients 
Basic description 
The seven surgical centres with the smallest lung cancer catchment populations covered only 8% of 
the national burden of lung cancer patients (Table 2), however in these centres the proportion of 
patients resected was slightly higher (14.8%) than that in the centres with larger lung cancer 
catchment populations (12.3%, 13.5% & 13.2% respectively) and this difference was on the 
borderline of statistical significance (log-likelihood p-value = 0.06). In the smallest lung cancer 
catchment population group, 59% of patients were first seen in a surgical centre compared with only 
15% in the largest lung cancer catchment population group. When adjusted for patient features, the 
likelihood of having surgery was marginally lower for people in larger lung cancer catchment 
populations (OR 0.87, 0.87 & 0.88) compared with those in the smallest catchment populations. 
Figure 1 represents the correlation between surgical centre lung cancer catchment population and 
number of surgeons and shows a moderate positive correlation between increasing catchment 
population and number of surgeons (Pearson’s correlation coefficient = 0.46 (95% CI 0.45 – 0.46)). 
All the surgical centres with the smallest lung cancer catchment population had 3 or fewer surgeons 
on-site, while only 1 of the 7 surgical centres with the largest lung cancer catchment population had 
more than 5 surgeons on-site. There was also no association seen between the number of 
cardiothoracic surgeons on site and the likelihood of having surgery (p-value = 0.88). 
Resection in patients first seen at a surgical centre compared with those first seen at a non-
surgical centre 
We divided patients into those who were first seen and managed by a surgical centre and patients who 
were first seen in non-surgical centres. Table 3 lists the proportions and the adjusted ORs of having 
surgery stratified by lung cancer catchment population. Overall, only 25% of the people with lung 
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cancer were first seen in a surgical centre and when adjusted for patient features, the odds of having 
surgery for these patients was 35% higher compared with patients first seen in a non-surgical centre 
(OR 1.35; 95% CI 1.27 - 1.43) (i.e. 17% vs 12% table 3). In the univariate analysis (data not shown), 
patient features most strongly associated were stage of the disease and PS. The proportions of surgical 
centre vs. non-surgical centre patients in the smallest catchment populations were similar (59% 
vs.41%), but this difference increased to almost 1:6 (15% vs. 85%) in the largest catchment 
populations. For surgical centres with a smaller catchment population size, there was no difference in 
the odds of having surgery between patients first seen in a surgical centre and patients first seen in the 
non-surgical centre (OR 0.98; 95% CI0.80 – 1.20). Whilst in surgical centres with a large catchment 
population size, patients first seen in a surgical centre were 57% more likely to have surgery 
compared with patients firsts seen in a non-surgical centre (OR 1.57; 95% CI 1.41 – 1.74). 
Surgical centres with a large catchment population were observed to have a higher resection rate on 
patients first seen in their own centre, compared with those patients first seen in a non-surgical centre 
in the surrounding area, and served by the same surgical centre (figure 2).  
Sensitivity analysis for stage I & II 
We performed similar analyses on patients with early stage disease (i.e. stage IA-IB (n=11,284) and 
IIA-IIB (n=5686)). Supplement table 1 presents the multivariate logistic regression analyses and the 
results show that the association between likelihood of having surgery and surgical centre lung cancer 
catchment population is more pronounced in patients with stage IA-IB (p value for trends <0.001) 
compared with the whole cohort and there is no significant association within the subgroup with stage 
IIA-IIB disease. In both groups, there was a higher proportion of patients resected in surgical centres 
with the smallest catchment size (62% stage I and 45% stage II) compared with surgical centres with 
the largest catchment size (53% stage I and 39% stage II).  
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DISCUSSION 
Our results demonstrate that the likelihood of having surgery for patients with NSCLC is 
independently influenced by patient features including age, sex, stage, performance status and 
comorbidity which are all part of clinically appropriate case selection. The likelihood of having 
surgery is also influenced by surgical centre features, most notably the surgical centre lung cancer 
catchment population. It was observed that as the lung cancer catchment population of surgical 
centres increases, the centre is more likely to operate on patients first seen ‘in house’ and less likely to 
operate on patients first seen at the non-surgical centres, even though this group of patients represents 
75% of the total lung cancer population overall and 85% of the patients for the centres with the large 
catchment population size. The same association was seen when we restricted our analyses to 
histologically proven cases only (data not shown).  
Strengths and limitations 
This study utilises a large dataset and its representative nature gives a true reflection of the diagnosis, 
treatment and management of patients with NSCLC in England. Although the data entry into the 
NLCA is non-mandatory, previous studies have shown that the missing data are unbiased.[4] As an 
added measure, for this study we used only data from 2008 onwards, when the NLCA case 
ascertainment achieved a level of more than 90%.[9, 10] Unlike studies which utilise large cancer 
registry data, [5, 12, 13] our linked dataset provides more information on co-morbidity and PS 
allowing for better case-mix adjustment. We used a valid measure of co-morbidity, the Charlson 
Index using the HES database which has shown coding accuracy of 91%.[14] The linked HES and 
NLCA database also allowed us to identify about 4% more surgically resected patients which would 
have been missed by using the NLCA data alone.[15] 
We utilised strict criteria to identify patients who had complete data on surgical centre and excluded 
2,500 patients who had surgery but incomplete accompanying data i.e. missing data on centre first 
seen or centre where patient had surgery. It is unlikely that these exclusions will have introduced bias 
as we have no reason to suspect that any one surgical centre had more missing data than the others. 
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We used number of cardiothoracic surgeons for 2010 only, but this is likely to be representative as it 
falls in the middle of the timeframe of our patient cohort. It was not possible to distinguish between 
operations performed by cardiothoracic surgeons compared with pure thoracic surgeons. Previous 
studies have reported that higher resection rates, better survival and the ability to handle complex 
operations are associated with specialist thoracic surgeons.[16-18] In addition, there could be other 
features of a surgical centre e.g. time to decision (for surgery), MDT composition and the number of 
lung cancer nurse specialists which may influence the timing of decisions and even patient 
willingness to undergo surgical resection. 
Comparison with other studies  
The findings in this study are in agreement with the observation from previous studies utilising UK 
and European databases; females are more likely to have surgery and have a better prognosis 
compared with males,[1, 2] while increasing age, co-morbidity, worsening PS and advanced stage 
disease were all unfavourable factors for having surgery and survival.[3, 4, 19] A previous study 
utilising the NLCA database by Rich et al [3] showed an increased odds (OR=1.51) of having surgery 
if the patient is first seen in a surgical centre, which were similar to our study, however our study is 
the first to identify odds of having surgery based on the lung cancer catchment population of a 
surgical centre. In addition, we were also able to show a significant trend association between 
socioeconomic status and odds of having surgery, mainly due to a more complete dataset than the 
previous study.  
Previous studies in the UK have highlighted geographical inequality in diagnosis and treatment based 
on where the patient is first seen and managed,[1, 3, 20, 21] while there are contrasting studies 
regarding hospital volume and survival.[22-24] Lau et al,[16] showed that increasing the number of 
cardiothoracic surgeons increased the resection rate of the centre, which is also seen in our study. 
However, our results would suggest that this increase would preferentially benefit ‘in house’ patients 
rather than patients first seen in a non-surgical centre. Lau et al also found no correlation between 
resection rates and annual number of NSCLC cases seen in all surgical and non-surgical centres 
13 
 
(Pearson’s correlation co-efficient = 0.0017). However we believe our results are more accurate as our 
data are not derived from surgical centres alone.  
Clinical Relevance 
This study has identified an inequality in lung cancer care provision. Surgical centres with large 
catchment populations have more surgeons to address the lung cancer burden, but are unable to 
provide equal access to surgery for patients seen at the non-surgical centres they serve, compared with 
patients presenting to their own centre. Our study is the first of its kind to look at the catchment 
population a surgical centre is responsible for, and to test the ‘hub and spoke model’. Ideally this 
model, with surgical centres drawing patients from surrounding centres allows the NHS to accurately 
redistribute its resources and manpower according to need in order to create equality in lung cancer 
care. Our study has highlighted the key role that the surgical centres with large catchment populations 
can play in improving the surgical resection rates in England, and the need to provide equal access to 
this service. 
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Table 1: Result of logistic regression analysis evaluating the association between patient feature and 
likelihood of having surgery (n=95,818) 
  
No. of patients 
(%) 
No. of patients 
with surgery 
(%) 
Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI) † 
χ2 p-value for 
trends 
Sex 
    
  
Female 41744 (43.57) 5833 (13.97) 1 1   
Male 54074 (56.43) 6926 (12.81) 0.90 (0.87 - 0.93) 0.94 (0.89 - 0.98) 0.018‡ 
Age 
    
  
<54 5937 (6.20) 1049 (17.67) 1 1   
55-59 6282 (6.56) 1134 (18.05) 1.02 (0.93 - 1.12) 1.01 (0.89 - 1.14)   
60-64 11220 (11.71) 2066 (18.41) 1.05 (0.96 - 1.14) 0.91 (0.81 - 1.01)   
65-69 14179 (14.80) 2614 (18.44) 1.05 (0.97 - 1.13) 0.92 (0.83 - 1.02)   
70-74 16560 (17.28) 2689 (16.24) 0.90 (0.83 - 0.97) 0.77 (0.69 - 0.85)   
75-79 16806 (17.54) 2082 (12.39) 0.65 (0.60 - 0.71) 0.55 (0.49 - 0.61)   
80-84 14073 (14.69) 940 (6.68) 0.33 (0.30 - 0.36) 0.25 (0.22 - 0.28)   
85+ 10761 (11.23) 185 (1.72) 0.08 (0.06 - 0.09) 0.06 (0.05 - 0.08) <0.001 
Stage 
    
  
IA-IB 11284 (11.78) 6189 (54.85) 1 1   
IIA-IIB 5686 (5.93) 2392 (42.07) 0.59 (0.56 - 0.63) 0.54 (0.50 - 0.58)   
IIIA 9249 (9.65) 1448 (15.66) 0.15 (0.14 - 0.16) 0.10 (0.09 - 0.11)   
IIIB 11697 (12.21) 474 (4.05) 0.03 (0.03 - 0.04) 0.02 (0.02 - 0.03)   
IV 39505 (41.23) 599 (1.52) 0.01 (0.01 - 0.02) 0.01 (0.01 - 0.01) <0.001 
Missing 18397 (19.20) 1657 (9.01) 0.08 (0.07 - 0.08) 0.07 (0.07 - 0.08)   
Performance Status 
   
  
0 15357 (16.03) 5245 (34.15) 1 1   
1 24945 (26.03) 4461 (17.88) 0.41 (0.40 - 0.43) 0.49 (0.46 - 0.52)   
2 16368 (17.08) 769 (4.70) 0.09 (0.08 - 0.10) 0.12 (0.11 - 0.14)   
3 15377 (16.05) 138 (0.90) 0.01 (0.01 - 0.02) 0.03 (0.02 - 0.03)   
4 5168 (5.39) 16 (0.31) 0.01 (0.01 - 0.01) 0.02 (0.01 - 0.03) <0.001 
Missing 18603 (19.41) 2130 (11.45) 0.24 (0.23 - 0.26) 0.36 (0.34 - 0.39)   
Ethnicity 
    
  
White 60396 (63.03) 8173 (13.53) 1 1   
Black 683 (0.71) 98 (14.35) 1.07 (0.86 - 1.32) 1.15 (0.86 - 1.53)   
Asian 827 (0.86) 120 (14.51) 1.08 (0.89 - 1.31) 1.10 (0.85 - 1.43)   
Mixed 107 (0.11) 17 (15.89) 1.20 (0.71 - 2.02) 0.97 (0.48 - 1.94)   
Others 737 (0.77) 100 (13.57) 1.00 (0.81 - 1.24) 1.15 (0.87 - 1.53)   
Missing 33068 (34.51) 4251 (12.86) 0.94 (0.90 - 0.98) 0.93 (0.89 - 0.99) 0.435‡ 
Townsend Quintile 
   
  
1 (Most affluent) 14975 (15.63) 2158 (14.41) 1 1   
2 17837 (18.62) 2444 (13.70) 0.94 (0.88 - 1.00) 0.89 (0.82 - 0.97)   
3 18839 (19.66) 2492 (13.23) 0.90 (0.85 - 0.96) 0.84 (0.78 - 0.92)   
4 20332 (21.22) 2645 (13.01) 0.88 (0.83 - 0.94) 0.83 (0.76 - 0.90)   
5 21966 (22.92) 2935 (13.36) 0.91 (0.86 - 0.97) 0.80 (0.74 - 0.87) <0.001 
Missing 1869 (1.95) 85 (4.55) 0.28 (0.22 - 0.35) 0.44 (0.34 - 0.58)   
Charlson Index 
    
  
0 29509 (30.80) 4830 (16.37) 1 1   
1 19001 (19.83) 3292 (17.33) 1.07 (1.01 - 1.12) 1.01 (0.95 - 1.08)   
2-3 17418 (18.18) 2721 (15.62) 0.94 (0.89 - 0.99) 0.99 (0.95 - 1.06)   
4+ 29890 (31.19) 1916 (6.41) 0.34 (0.33 - 0.36) 0.78 (0.73 - 0.84) 0.003 
Source of 
referral 
    
  
Referral from GP 45465 (47.45) 7167 (15.76) 1 1   
Emergency Adm. 11991 (12.51) 480 (4.00) 0.22 (0.20 - 0.24) 0.54 (0.48 - 0.60)   
Ref. from 20137 (21.02) 3295 (16.36) 1.04 (0.99 - 1.09) 1.12 (1.05 - 1.19)   
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Consultant 
Other Sources 16115 (16.82) 1564 (9.71) 0.57 (0.54 - 0.60) 0.87 (0.81 - 0.94) <0.001‡ 
Missing 2110 (2.20) 253 (11.99) 0.72 (0.63 - 0.83) 0.85 (0.72 - 1.01)   
† Odd ratio adjusted for every other variable in the table       
‡ Log likelihood ratio test 
     
Table 2: Result of logistic regression analysis evaluating the association between centre feature and 
likelihood of having surgery (n=95,818) 
  
No. of patients 
(%) 
No. of patients 
with surgery 
(%) 
Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI) † 
χ2 p-value log-
likelihood ratio 
test 
Surgical centre annual catchment population  
<400 7566 (8) 1122 (15) 1 1   
400-700 15581 (16) 1929 (12) 0.81 (0.74 - 0.87) 0.87 (0.78 - 0.97)   
700-1100 33009 (34) 4464 (14) 0.89 (0.83 - 0.96) 0.87 (0.79 - 0.95)   
>1100 39662 (41) 5244 (13) 0.87 (0.81 - 0.93) 0.88 (0.80 - 0.96) 0.06 
Number of Cardiothoracic Surgeons on-site 
  
  
≤3 surgeons 26493 (28) 3517 (13) 1 1   
>3 - ≤5 surgeons 51579 (64) 8095 (13) 0.98 (0.94 - 1.03) 0.99 (0.93 - 1.05)   
>5 surgeons 7746 (8) 1147 (15) 1.13 (1.05 - 1.22) 0.99 (0.90 - 1.09) 0.88 
† Adjusted for patient features only 
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Table 3: Odds of having surgery for non-surgical centre patients and surgical centre patients by surgical centre catchment population (n=95,818) 
  
Patients first seen in a non-surgical 
centre (n=71,777) 
Patients first seen in a surgical 
centre (n=24,041) 
 
Surgical centre 
lung cancer 
catchment 
population (n) 
‡ Number of 
patients 
(percentage) 
Number of 
patients with 
surgery n 
(percentage of ‡) 
§ Number of 
patients 
(percentage) 
Number of 
patients with 
surgery n 
(percentage of 
§) Unadjusted OR (95% CI) Adjusted OR (95% CI)† ɸ 
<400 3122 (41) 414 (13) 4444 (59) 708 (16) 1.23 (1.08 - 1.41) 0.98 (0.80 - 1.20) 
400 - 700 11392 (73) 1344 (12) 4189 (27) 585 (14) 1.21 (1.09 - 1.34) 1.02 (0.88 - 1.18) 
700 - 1100 23564 (71) 2820 (12) 9445 (29) 1644 (17) 1.55 (1.45 - 1.65) 1.46 (1.33 - 1.61) 
>1100 33699 (85) 4161 (12) 5963 (15) 1083 (18) 1.57 (1.46 - 1.69) 1.52 (1.37 - 1.68) 
Overall 71777 (75) 8739 (12) 24041 (25) 4020 (17) 1.44 (1.39 - 1.50) 1.35 (1.27 - 1.43) 
† Adjusted for age, sex, PS, stage, co-morbidity, ethnicity, source of referral, SES and number of cardiothoracic surgeons 
ɸ Comparison between patients first seen at a surgical centre and those first seen at a non-surgical centre within the same group of lung cancer catchment 
population. 
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